These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25592653)

  • 1. [The VR, the Russian version of the nerve agent VX].
    Cuquel AC; Dorandeu F; Ceppa F; Renard C; Burnat P
    Ann Pharm Fr; 2015 May; 73(3):180-9. PubMed ID: 25592653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
    Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
    Reiter G; Müller S; Hill I; Weatherby K; Thiermann H; Worek F; Mikler J
    Toxicol Lett; 2015 Jan; 232(2):438-48. PubMed ID: 25448275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
    Mikler J; Tenn C; Worek F; Reiter G; Thiermann H; Garrett M; Bohnert S; Sawyer TW
    Toxicol Lett; 2011 Sep; 206(1):47-53. PubMed ID: 21704135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity Based Protein Profiling Leads to Identification of Novel Protein Targets for Nerve Agent VX.
    Carmany D; Walz AJ; Hsu FL; Benton B; Burnett D; Gibbons J; Noort D; Glaros T; Sekowski JW
    Chem Res Toxicol; 2017 Apr; 30(4):1076-1084. PubMed ID: 28267914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
    Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSDL decontamination of human skin contaminated with the nerve agent VX.
    Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
    Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reactivating and therapeutic efficacy of oximes to counteract Russian VX poisonings.
    Kassa J; Jun D; Kuca K
    Int J Toxicol; 2006; 25(5):397-401. PubMed ID: 16940011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reaction of oximes with crotylsarin, cyclosarin, or VX in vitro.
    Becker G; Kawan A; Gutzeit D; Worek F; Szinicz L
    Arch Toxicol; 2007 Jun; 81(6):415-20. PubMed ID: 17151865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and reaction networks of H2O2 vapor with NH3 gas for decontamination of the toxic warfare nerve agent, VX on a solid surface.
    Gon Ryu S; Wan Lee H
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(14):1417-27. PubMed ID: 26327407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
    Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
    Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent.
    Kuca K; Jun D; Cabal J; Hrabinova M; Bartosova L; Opletalova V
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):389-94. PubMed ID: 16623863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the Ocular Treatment Following Organophosphate Nerve Agent Insult.
    Egoz I; Nili U; Grauer E; Gore A
    Toxicol Sci; 2017 Sep; 159(1):50-63. PubMed ID: 28903494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of inhibitors and other factors on cholinesterases.
    Bajgar J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991; 34(1):5-77. PubMed ID: 1759111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of LCt(50)s in anesthetized rats exposed to aerosolized nerve agents.
    Collins JL; Peng X; Lee R; Witriol A; Pierre Z; Sciuto AM
    Toxicol Mech Methods; 2013 Feb; 23(2):127-33. PubMed ID: 22978758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
    Maxwell DM; Koplovitz I; Worek F; Sweeney RE
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsive and protective effects of diazepam and midazolam in rats poisoned by highly toxic organophosphorus compounds.
    Bokonjić D; Rosić N
    Arh Hig Rada Toksikol; 1991 Dec; 42(4):359-65. PubMed ID: 1815490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.